Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.

@article{Ni2014LungLP,
  title={Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.},
  author={J Dong Ni and L-J Qiu and L-F Hu and Han Cen and Min Zhang and P Wen and Xi Wang and H-F Pan and Dong Ye},
  journal={Lupus},
  year={2014},
  volume={23 3},
  pages={284-92}
}
OBJECTIVE The objective of this paper is to examine some solid tumors incidence in patients with systemic lupus erythematosus (SLE) derived from population-based cohort studies by means of meta-analysis. METHODS Relevant electronic databases were searched for studies characterizing the associated risk of overall malignancy and four site-specific malignancies (lung, liver, prostate, bladder cancer) in patients with SLE. The meta-analysis procedure was used to pool standardized incidence rates… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

A review on SLE and malignancy.

Best practice & research. Clinical rheumatology • 2017
View 1 Excerpt
Highly Influenced

The evolving concept of SLE comorbidities.

Expert review of clinical immunology • 2017
View 2 Excerpts

Similar Papers

Loading similar papers…